Transcriptomics

Dataset Information

0

Arachidonic acid triggers spermidine synthase secretion from primary tumor to induce skeletal muscle weakness upon irradiation


ABSTRACT: Radiotherapy (RT) reduces the risk of cancer recurrence and death, while accompanied by multiple side effects including muscle weakness, seriously affects the life quality of patients. However, the underlying mechanism is not well defined. Here, we identify cancer cells secrete more spermidine synthase (SRM) protein through small extracellular vesicles (sEVs) to trigger skeletal muscle weakness upon RT. Mechanistically, RT-triggered arachidonic acid (ArA) accumulation elevates the ISGylation of SRM protein, facilitating SRM package into EVs from primary tumor. Circulating SRM proteins enhance spermidine accumulation in skeletal muscle and type I collagen fibers biosynthesis in an eIF5A-dependent manner. Deposition of randomly aligned collogen fibers induced by SRM+ EVs results in skeletal muscle fibrosis and weakness, as well as bone matrix loss. However, losartan treatment blocks the ISGylation of SRM and its subsequent secretion. Collectively, our findings determine that ArA functions in concert for circulating SRM secretion upon RT, which aggravates skeletal muscle fibrosis through rewiring polyamine metabolism, shedding light on the alleviation of RT-mediated muscle weakness when combined with losartan treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE285652 | GEO | 2025/04/03

REPOSITORIES: GEO

Shared Molecules

Only show the datasets with similarity scores above: 0.5
     

Similar Datasets

2025-04-03 | GSE263507 | GEO
2025-04-03 | GSE263505 | GEO
2025-04-03 | GSE263508 | GEO
2025-04-03 | GSE263506 | GEO
2021-12-31 | GSE138768 | GEO
2024-05-22 | PXD046596 | Pride
2021-12-31 | GSE108828 | GEO
2018-05-04 | PXD008145 | Pride
2016-04-01 | E-GEOD-67803 | biostudies-arrayexpress
2016-05-17 | MSV000079730 | MassIVE